{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:19:12Z","timestamp":1791983952093,"version":"4.4.0"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T00:00:00Z","timestamp":1544227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5F32NS095508-03"],"award-info":[{"award-number":["5F32NS095508-03"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD020012-01"],"award-info":[{"award-number":["S10OD020012-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,20]]},"DOI":"10.1093\/nar\/gky1232","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T23:24:16Z","timestamp":1544138656000},"page":"1070-1081","source":"Crossref","is-referenced-by-count":142,"title":["Hydrophobicity drives the systemic distribution of lipid-conjugated siRNAs via lipid transport pathways"],"prefix":"10.1093","volume":"47","author":[{"given":"Maire F","family":"Osborn","sequence":"first","affiliation":[{"name":"RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA"},{"name":"Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3218-6957","authenticated-orcid":false,"given":"Andrew H","family":"Coles","sequence":"additional","affiliation":[{"name":"RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA"},{"name":"Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"Biscans","sequence":"additional","affiliation":[{"name":"RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA"},{"name":"Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reka A","family":"Haraszti","sequence":"additional","affiliation":[{"name":"RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA"},{"name":"Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Roux","sequence":"additional","affiliation":[{"name":"RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA"},{"name":"Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Davis","sequence":"additional","affiliation":[{"name":"RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA"},{"name":"Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7320-4763","authenticated-orcid":false,"given":"Socheata","family":"Ly","sequence":"additional","affiliation":[{"name":"RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA"},{"name":"Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimas","family":"Echeverria","sequence":"additional","affiliation":[{"name":"RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA"},{"name":"Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R","family":"Hassler","sequence":"additional","affiliation":[{"name":"RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA"},{"name":"Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno M D C","family":"Godinho","sequence":"additional","affiliation":[{"name":"RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA"},{"name":"Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"Nikan","sequence":"additional","affiliation":[{"name":"RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA"},{"name":"Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Khvorova","sequence":"additional","affiliation":[{"name":"RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA"},{"name":"Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,12,8]]},"reference":[{"key":"key\n\t\t\t\t2019021903223312200_B1","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/mt.2009.91","article-title":"The effect of chemical modification and nanoparticle formulation on stability and biodistribution of siRNA in mice","volume":"17","author":"Gao","year":"2009","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t2019021903223312200_B2","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1093\/nar\/gkw236","article-title":"The delivery of therapeutic oligonucleotides","volume":"44","author":"Juliano","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t2019021903223312200_B3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1609243","article-title":"A highly durable RNAi therapeutic inhibitor of PCSK9","volume":"376","author":"Fitzgerald","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t2019021903223312200_B4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.omtn.2016.12.003","article-title":"Preclinical and clinical advances of GalNAc-Decorated nucleic acid therapeutics","volume":"6","author":"Huang","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"key\n\t\t\t\t2019021903223312200_B5","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/mt.2008.14","article-title":"Efficient in vivo delivery of siRNA to the liver by conjugation of alpha-Tocopherol","volume":"16","author":"Nishina","year":"2008","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t2019021903223312200_B6","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nbt1339","article-title":"Mechanisms and optimization of in vivo delivery of lipophilic siRNAs","volume":"25","author":"Wolfrum","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"key\n\t\t\t\t2019021903223312200_B7","doi-asserted-by":"crossref","first-page":"E6490","DOI":"10.1073\/pnas.1621240114","article-title":"Lipophilic siRNA targets albumin in situ and promotes bioavailability, tumor penetration, and carrier-free gene silencing","volume":"114","author":"Sarett","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"key\n\t\t\t\t2019021903223312200_B8","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1093\/nar\/gky037","article-title":"Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo","volume":"46","author":"Hassler","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t2019021903223312200_B9","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1038\/mtna.2016.50","article-title":"Docosahexaenoic acid conjugation enhances distribution and safety of siRNA upon local administration in mouse brain","volume":"5","author":"Nikan","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"key\n\t\t\t\t2019021903223312200_B10","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.1038\/mtna.2015.38","article-title":"Hydrophobically modified siRNAs silence huntingtin mRNA in primary neurons and mouse brain","volume":"4","author":"Alterman","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"key\n\t\t\t\t2019021903223312200_B11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1089\/nat.2015.0578","article-title":"A High-Throughput method for direct detection of therapeutic Oligonucleotide-Induced gene silencing in vivo","volume":"26","author":"Coles","year":"2016","journal-title":"Nucleic Acid Ther."},{"key":"key\n\t\t\t\t2019021903223312200_B12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"key\n\t\t\t\t2019021903223312200_B13","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00418-009-0577-1","article-title":"Cellular organization of normal mouse Liver: A histological, quantitative immunocytochemical, and fine structural analysis","volume":"131","author":"Baratta","year":"2009","journal-title":"Histochem. Cell Biol."},{"key":"key\n\t\t\t\t2019021903223312200_B14","doi-asserted-by":"crossref","first-page":"7581","DOI":"10.1093\/nar\/gkx507","article-title":"5-Vinylphosphonate improves tissue accumulation and efficacy of conjugated siRNAs in vivo","volume":"45","author":"Haraszti","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t2019021903223312200_B15","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1021\/acs.bioconjchem.7b00226","article-title":"Synthesis and evaluation of parenchymal retention and efficacy of a metabolically stable O-Phosphocholine-N-docosahexaenoyl-l-serine siRNA conjugate in mouse brain","volume":"28","author":"Nikan","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"key\n\t\t\t\t2019021903223312200_B16","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1021\/jm049167j","article-title":"Fully 2\u2032-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA","volume":"48","author":"Allerson","year":"2005","journal-title":"J. Med. Chem."},{"key":"key\n\t\t\t\t2019021903223312200_B17","first-page":"987","article-title":"5\u2032-(E)-Vinylphosphonate: a stable phosphate mimic can improve the RNAi activity of siRNA\u2013GalNAc conjugates","volume":"17","author":"Parmar","year":"2016","journal-title":"ChemBioChem"},{"key":"key\n\t\t\t\t2019021903223312200_B18","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/j.bmcl.2016.04.063","article-title":"Synergistic effect of phosphorothioate, 5\u2032-vinylphosphonate and GalNAc modifications for enhancing activity of synthetic siRNA","volume":"26","author":"Prakash","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"key\n\t\t\t\t2019021903223312200_B19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2012.08.014","article-title":"Single-stranded siRNAs activate RNAi in animals","volume":"150","author":"Lima","year":"2012","journal-title":"Cell"},{"key":"key\n\t\t\t\t2019021903223312200_B20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.addr.2015.01.008","article-title":"Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides","volume":"87","author":"Geary","year":"2015","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"key\n\t\t\t\t2019021903223312200_B21","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/jop.2013.0148","article-title":"Novel hydrophobically modified asymmetric RNAi compounds (sd-rxRNA) demonstrate robust efficacy in the eye","volume":"29","author":"Byrne","year":"2013","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"key\n\t\t\t\t2019021903223312200_B22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/nat.2017.0690","article-title":"Pharmacokinetic profiling of conjugated therapeutic Oligonucleotides: A High-Throughput method based upon serial blood microsampling coupled to peptide nucleic acid hybridization assay","volume":"27","author":"Godinho","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"key\n\t\t\t\t2019021903223312200_B23","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1021\/la504270a","article-title":"Hydrophobicity is the governing factor in the interaction of human serum albumin with bile salts","volume":"31","author":"Ghosh","year":"2015","journal-title":"Langmuir"},{"key":"key\n\t\t\t\t2019021903223312200_B24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1530\/JOE-15-0023","article-title":"Adrenocortical LDL receptor function negatively influences glucocorticoid output","volume":"226","author":"van\u00a0der\u00a0Sluis","year":"2015","journal-title":"J. Endocrinol."},{"key":"key\n\t\t\t\t2019021903223312200_B25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/nat.2017.0662","article-title":"Co-Administration of an excipient oligonucleotide helps delineate pathways of productive and nonproductive uptake of phosphorothioate antisense oligonucleotides in the liver","volume":"27","author":"Donner","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"key\n\t\t\t\t2019021903223312200_B26","doi-asserted-by":"crossref","first-page":"17035","DOI":"10.1038\/srep17035","article-title":"Enteral siRNA delivery technique for therapeutic gene silencing in the liver via the lymphatic route","volume":"5","author":"Murakami","year":"2015","journal-title":"Sci. Rep."},{"key":"key\n\t\t\t\t2019021903223312200_B27","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/nar\/gkx060","article-title":"Characterizing the effect of GalNAc and phosphorothioate backbone on binding of antisense oligonucleotides to the asialoglycoprotein receptor","volume":"45","author":"Schmidt","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t2019021903223312200_B28","doi-asserted-by":"crossref","first-page":"12388","DOI":"10.1093\/nar\/gkx960","article-title":"Asialoglycoprotein receptor 1 mediates productive uptake of N-acetylgalactosamine-conjugated and unconjugated phosphorothioate antisense oligonucleotides into liver hepatocytes","volume":"45","author":"Tanowitz","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t2019021903223312200_B29","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1021\/acs.bioconjchem.8b00365","article-title":"Novel cluster and Monomer-Based GalNAc structures induce effective uptake of siRNAs in vitro and in vivo","volume":"29","author":"Sharma","year":"2018","journal-title":"Bioconjugate Chem."},{"key":"key\n\t\t\t\t2019021903223312200_B30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ymthe.2016.10.019","article-title":"Clinical proof of concept for a novel hepatocyte-targeting GalNAc-siRNA conjugate","volume":"25","author":"Zimmermann","year":"2017","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t2019021903223312200_B31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.omtn.2016.12.003","article-title":"Preclinical and clinical advances of GalNAc-decorated nucleic acid therapeutics","volume":"6","author":"Huang","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"key\n\t\t\t\t2019021903223312200_B32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/nat.2017.0690","article-title":"Pharmacokinetic profiling of conjugated therapeutic Oligonucleotides: A High-Throughput method based upon serial blood microsampling coupled to peptide nucleic acid hybridization assay","volume":"27","author":"Godinho","year":"2017","journal-title":"Nucleic Acid Ther."},{"key":"key\n\t\t\t\t2019021903223312200_B33","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1681\/ASN.2008111204","article-title":"siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury","volume":"20","author":"Molitoris","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"key\n\t\t\t\t2019021903223312200_B34","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nbt.3765","article-title":"The chemical evolution of oligonucleotide therapies of clinical utility","volume":"35","author":"Khvorova","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"key\n\t\t\t\t2019021903223312200_B35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12967-015-0387-2","article-title":"Fighting against kidney diseases with small interfering RNA: opportunities and challenges","volume":"13","author":"Yang","year":"2015","journal-title":"J. Transl. Med."},{"key":"key\n\t\t\t\t2019021903223312200_B36","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.1021\/jacs.7b02917","article-title":"Development of DNA nanostructures for High-Affinity binding to human serum albumin","volume":"139","author":"Lacroix","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"key\n\t\t\t\t2019021903223312200_B37","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1172\/JCI116663","article-title":"Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery","volume":"92","author":"Ishibashi","year":"1993","journal-title":"J. Clin. Invest."},{"key":"key\n\t\t\t\t2019021903223312200_B38","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0022-2275(20)32023-X","article-title":"Relative importance of the LDL receptor and scavenger receptor class B in the beta-VLDL-induced uptake and accumulation of cholesteryl esters by peritoneal macrophages","volume":"41","author":"Herijgers","year":"2000","journal-title":"J. Lipid Res."},{"key":"key\n\t\t\t\t2019021903223312200_B39","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nbt.3779","article-title":"Cellular uptake and trafficking of antisense oligonucleotides","volume":"35","author":"Crooke","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"key\n\t\t\t\t2019021903223312200_B40","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/j.bmcl.2016.04.063","article-title":"Synergistic effect of phosphorothioate, 5\u2032-vinylphosphonate and GalNAc modifications for enhancing activity of synthetic siRNA","volume":"26","author":"Prakash","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"key\n\t\t\t\t2019021903223312200_B41","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/nat.2012.0371","article-title":"Toxicological and pharmacokinetic properties of chemically modified siRNAs targeting p53 RNA following intravenous administration","volume":"22","author":"Thompson","year":"2012","journal-title":"Nucleic Acid Ther"},{"key":"key\n\t\t\t\t2019021903223312200_B42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1056\/NEJMp1614154","article-title":"Oligonucleotide therapeutics - a new class of Cholesterol-Lowering drugs","volume":"376","author":"Khvorova","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t2019021903223312200_B43","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1093\/nar\/gky037","article-title":"Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo","volume":"46","author":"Hassler","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t2019021903223312200_B44","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/smll.201001589","article-title":"Efficient cytosolic delivery of siRNA using HDL-mimicking nanoparticles","volume":"7","author":"Yang","year":"2011","journal-title":"Small"},{"key":"key\n\t\t\t\t2019021903223312200_B45","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/smll.200901515","article-title":"HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting","volume":"6","author":"Zhang","year":"2010","journal-title":"Small"},{"key":"key\n\t\t\t\t2019021903223312200_B46","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2217\/nnm.12.73","article-title":"Efficient systemic delivery of siRNA by using high-density lipoprotein-mimicking peptide lipid nanoparticles","volume":"7","author":"Lin","year":"2012","journal-title":"Nanomedicine (Lond.)"},{"key":"key\n\t\t\t\t2019021903223312200_B47","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/mt.2012.33","article-title":"Harnessing a physiologic mechanism for siRNA delivery with mimetic lipoprotein particles","volume":"20","author":"Nakayama","year":"2012","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t2019021903223312200_B48","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1038\/mt.2011.186","article-title":"Efficient in vivo delivery of siRNA into brain capillary endothelial cells along with endogenous lipoprotein","volume":"19","author":"Kuwahara","year":"2011","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t2019021903223312200_B49","doi-asserted-by":"crossref","first-page":"15144","DOI":"10.1038\/ncomms15144","article-title":"Lipoprotein-biomimetic nanostructure enables efficient targeting delivery of siRNA to Ras-activated glioblastoma cells via macropinocytosis","volume":"8","author":"Huang","year":"2017","journal-title":"Nat. Commun."},{"key":"key\n\t\t\t\t2019021903223312200_B50","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejpb.2016.08.005","article-title":"Development of novel HDL-mimicking alpha-tocopherol-coated nanoparticles to encapsulate nerve growth factor and evaluation of biodistribution","volume":"108","author":"Prathipati","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"key\n\t\t\t\t2019021903223312200_B51","doi-asserted-by":"crossref","first-page":"8893","DOI":"10.1016\/j.biomaterials.2012.08.057","article-title":"A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy","volume":"33","author":"Ding","year":"2012","journal-title":"Biomaterials"},{"key":"key\n\t\t\t\t2019021903223312200_B52","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nature02302","article-title":"A conserved siRNA-degrading RNase negatively regulates RNA interference in C. elegans","volume":"427","author":"Kennedy","year":"2004","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019021903223312200_B53","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1021\/acsnano.5b07522","article-title":"High-density lipoproteins: nature's multifunctional nanoparticles","volume":"10","author":"Kuai","year":"2016","journal-title":"ACS Nano"},{"key":"key\n\t\t\t\t2019021903223312200_B54","first-page":"3637","article-title":"Nanoparticle-based delivery of small interfering RNA: Challenges for cancer therapy","volume":"7","author":"Miele","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"key\n\t\t\t\t2019021903223312200_B55","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.4297","article-title":"RNAi modulation of placental sFLT1 for the treatment of preeclampsia","author":"Turanov","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"key\n\t\t\t\t2019021903223312200_B56","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1038\/mtna.2016.55","article-title":"Silencing myostatin using Cholesterol-conjugated siRNAs induces muscle growth","volume":"5","author":"Khan","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/47\/3\/1070\/27853821\/gky1232.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T16:41:09Z","timestamp":1662568869000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/article\/47\/3\/1070\/5235412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,8]]},"references-count":56,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,12,8]]},"published-print":{"date-parts":[[2019,2,20]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gky1232","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/288092","asserted-by":"object"}]},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2,20]]},"published":{"date-parts":[[2018,12,8]]}}}